Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs

Source: Business Insider

Isomorphic Labs president Max Jaderberg believes that in five years' time, all drugs will be designed by AI. Jillian Edelstein for BIIn a cavernous office in London's AI hub, a group of researchers is preparing to do battle with humanity's oldest enemy. Isomorphic Labs, a spinoff of Google DeepMind and the brainchild of AI pioneer Demis Hassabis, has an ambitious mission even by the standards of other AI labs: using AI to create drugs that could cure cancer and make disease a thing of the past.